Population health management tools can facilitate the development and maintenance of care plans for high-risk patients.
Participating practices point to a number of successes attributable to OCM, even as they grapple with challenges presented by the model.
This webinar reviews the findings of ECG’s 11th annual Pediatric Subspecialty Physician Compensation Survey. The session includes our analysis of important physician and advanced practice provider performance trends from the 2017 survey. A particular focus of this webinar is on market trends related to value-based provider compensation planning and how those plans integrate with overall organization strategies.
ECG’s team of experts review the findings of our 18th annual Physician Compensation Survey. The session includes analysis of important physician and advanced practice provider performance trends from the 2017 survey. A particular focus is on market trends related to value-based provider compensation planning and how those plans integrate with overall organization strategies.
ECG announced that Hector Torres has joined the firm as principal and head of the Mergers, Acquisitions, and Partnerships practice.
Part one of this series reviewed the steps leading up to a pilot program go-live. In this post, we will review ongoing pilot management after go-live and planning for the future.
Based on our latest whitepaper, this webinar examines market dynamics that are pushing ambulatory surgery to the forefront of the healthcare delivery. Presenters highlight the ways in which health systems are looking at Ambulatory Surgery Center development and joint ventures as an opportunity to partner with physicians and other organizations to effectively implement an ambulatory surgery strategy.
Before jumping in headfirst with any transformational initiatives across the entire organization, consider starting with a pilot.
Recent changes to CMS’s Hospital Outpatient Prospective Payment System (OPPS) rule for CY 2018 have created a stir across the healthcare industry due to the profound impact on organizations participating in the 340B Drug Pricing Program.
Page 26 of 280